Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Targeting CD123 in AML: The Latest Therapeutic Advancements
Targeting CD123 in AML: The Latest Therapeutic Advancements
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Alleviating Anemia in Myelofibrosis: New Therapeutic Avenues
Alleviating Anemia in Myelofibrosis: New Therapeutic Avenues
Managing Anemia in Myelofibrosis: A Multidisciplinary Approach
Managing Anemia in Myelofibrosis: A Multidisciplinary Approach
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
